9 reports

CHRONIC PAIN AND MENTAL HEALTH ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##.

  • Pathology
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

EXAMPLE HIGHLIGHTS ##.

  • Mental Health
  • Pathology
  • World

TARGET PATIENT POPULATION CHRONIC PAIN IN HIP AND KNEE OSTEOARTHRITIS Source: Roots Analysis ##. ##. ##. ##.

  • Pathology
  • North America
  • United States
  • Ironwood Pharmaceuticals, Inc.
  • Novo Nordisk Group

TARGET PATIENT POPULATION TABLE ##. ## NKTR-##: TARGET PATIENT POPULATION CHRONIC LOW BACK PAIN CHRONIC OA KNEE PAIN Source: Roots Analysis ##. ##. ##. ##. ##.

  • Clinical Trial
  • Drug Delivery
  • Pathology
  • Pharmaceutical
  • Therapy

A TOTAL OF ## ADVERSE EVENTS WERE REPORTED; OF THESE, ABDOMINAL PAIN / CRAMPING, CONSTIPATION, DIARRHEA AND ATULENCE WERE THE MOST COMMON ONES.

  • Clinical Trial
  • Pathology
  • Pharmaceutical
  • Therapy
  • United States

PEPTIDE THERAPEUTICS BASED ON THE PEPTELLIGENCE™ TECHNOLOGY VARIOUS MOLECULES ARE CURRENTLY UNDER DEVELOPMENT USING THE PEPTELLIGENCE™ TECHNOLOGY FOR THE TREATMENT OF VARIOUS INDICATIONS SUCH AS OSTEOPOROSIS, OSTEOPENIA AND NEUROPATHIC PAIN, ACUTE AND CHRONIC PAIN., SPECIF

  • Clinical Trial
  • Diabetes
  • Endocrine Disease
  • Pathology
  • Therapy

One way is through the induction of chronic inflammation and the other through the production of bacterial metabolites.

  • Obesity
  • Pathology
  • Pharmaceutical
  • Therapy
  • United States

THE PRODUCT IS A BUPRENORPHINE INJECTION FOR TREATING OPIOID DEPENDENCE AND CHRONIC PAIN.

  • Analgesic
  • Antipsychotic
  • Opioid
  • Pathology
  • Vaccine

IT IS INDICATED TO PROVIDE TREATMENT AGAINST CHRONIC PAIN.

  • Pathology
  • Therapy
  • United States
  • Company
  • ArmaGen